Pierre Guerreschi
Co-fondateur

Lattice Medical develops 3D printed bioabsorbable implants for breast reconstruction and soft tissue regeneration, utilizing advanced biomaterials and tissue engineering techniques. Their products, MATTISSE and RODIN, address the need for effective and safe solutions in reconstructive surgery, enhancing patient recovery and outcomes.
Raised to date
$5.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Co-fondateur
Current breast reconstruction and soft tissue regeneration techniques often lack effective, safe, and natural-feeling solutions, leading to suboptimal aesthetic outcomes and potential complications for patients. Existing options may not fully integrate with the body's tissues or provide long-term regenerative benefits.
Lattice Medical develops 3D-printed, bioabsorbable implants designed to regenerate soft tissues, offering a more natural and integrated approach to reconstructive surgery. Their MATTISSE implant serves as a resorbable mammary prosthesis, while RODIN is a matrix engineered to regenerate the hypodermis. Both devices leverage advanced biomaterials and tissue engineering principles to promote tissue integration and regeneration, aiming to improve patient outcomes and quality of life. The implants are designed to be gradually absorbed by the body as new tissue grows, leaving behind a natural, regenerated structure.
The primary target audience includes reconstructive surgeons, plastic surgeons, and hospitals specializing in breast reconstruction and soft tissue regeneration procedures.